respiratory syncytial virus, Rsv
The Nobel Prize in medicine was awarded to Victor Ambros, PhD, of the University of Massachusetts, and Gary Ruvkun, PhD, of ...
Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.
In another positive development, Pfizer won a bid in a London court to invalidate two of GSK Plc’s GSK patents relating to its respiratory syncytial virus (RSV) vaccine. Also Read: UK Chooses ...
The complex shape of respiratory syncytial virus (RSV) is one hurdle limiting the development of treatments for an infection ...
A new COVID variant, XEC, is gaining traction in the U.S. and is estimated to account for up to 13% of cases. The strain is a recombinant of two JN.1 lineage viruses, with new COVID shots expected to ...
In anticipation of the winter season an increased circulation of respiratory viruses is expected with a peak in the coming weeks – and the free fall vaccination campaign will begin soon. Quebec’s ...